- Press Release Distribution

Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer

Researchers from Japan demonstrate that gene editing can enhances the effectiveness of rejuvenated cytotoxic T lymphocytes for targeted immunotherapy

Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer

Cervical cancer is among the most common malignancies affecting women worldwide. In 2020 alone, approximately 600,000 women were diagnosed with this disease, and over 314,000 died from it. In 99% of the cases, cervical cancer cells harbor human papilloma virus (HPV), and thus, HPV vaccines are an effective way to mitigate the risk of developing this disease. Unfortunately, such preventive measures are useless against established cancers, which are generally incurable once they become metastatic or relapsing.


Fortunately, scientists have made substantial progress in developing a promising therapeutic strategy for cervical cancer: rejuvenated cytotoxic T lymphocytes (rejTs). These lymphocytes can be engineered to target HPV-specific antigens that are expressed predominantly in cervical cancer cells, constituting a type of targeted immunotherapy. Ideally, rejTs would be produced from induced pluripotent stem cells (iPSCs) gathered from the patient themselves. However, this process is not clinically feasible in terms of both time and cost.


Against this backdrop, a research team including Chief Professor Miki Ando, graduate student Yoshiki Furukawa, and Assistant Professor Midori Ishii from Juntendo University School of Medicine, Japan, has recently achieved a breakthrough by developing robust iPSC-derived rejTs for cervical cancer treatment. Their work was published online on December 12, 2023, in Cell Reports Medicine.


The team sought to address one of the key roadblocks for allogeneic iPSC-derived rejTs, which refers to rejTs produced from ‘standardized’ iPSCs rather than derived from the patient’s cells. Prof. Ando explains, “In immunocompetent cervical cancer patients, the dominant problem is the rejection of foreign T lymphocytes by the recipient’s CD8+ T lymphocytes or natural killer (NK) cells.” The patient’s immune system tends to attack the therapeutic HPV-specific rejTs before they can neutralize cancer cells.


To overcome this issue, the research team used CRISPR-Cas9 two-step “scarless” gene editing on iPSCs derived from an HPV-specific cytotoxic T lymphocyte clone. The first modification was the deletion of all HLA class I antigens from the cells. The role of these surface protein is to present peptides to CD8+ T lymphocytes, which promptly eliminate any cells displaying foreign or anomalous peptides. After the modification, the cells are essentially able to evade detection by CD8+ T lymphocytes.


The second modification involved introducing the limited expression of two specific HLA antigens, namely HLA-A24 and HLA-E. This enabled the engineered cells to evade attacks from NK cells, which specifically target cells lacking these surface antigens. By selecting HLA-A24, the engineered cells are naturally compatible with a significant portion of South American, Eastern Asian, North American, and European populations.


After implementing these modifications using CRISPR-Cas9, the researchers induced the differentiation of the iPSCs into T lymphocytes and tested their ability to fight cervical cancer cells while evading allogeneic immune responses both in vitro and in vivo. These experiments yielded very promising results, as the generated rejTs did not trigger attacks from either CD8+ T cells or NK cells while simultaneously achieving strong cytotoxicity against tumor cells.


Compared to the control group, mice engrafted with cervical cancer cells and injected with the gene-edited rejTs survived longer and exhibited significantly reduced tumor sizes and proliferation index. To gain further insights into the enhanced therapeutic effects of the rejTs, the researchers conducted single-cell RNA sequencing analyses. These analyses revealed that the population of rejTs was highly enriched with tissue resident memory T cells, which establish residence in the mucosa of the cervix and provide stronger protection. Prof. Ando remarks, “We found that the enhanced cytotoxicity against cervical cancer occurred through TGFβ signaling and increased CD103 expression.”


Taken together, the results of this study showcase a powerful method to make iPSC-derived rejTs a viable option to treat one of the most common forms of cancer. Prof Ando concludes, “The HLA-engineered HPV-rejTs obtained using our method provide a sustainable and promising approach toward successful ‘off-the-shelf’ T cell therapy, which could help in overcoming cervical cancer. We are planning on conducting an investigator-initiated clinical trial in 2024.”








Yoshiki Furukawaa, Midori Ishiia, Jun Andoa,b, Kazuya Ikedac, Kyomi J. Igarashid, Shintaro Kinoshitaa, Yoko Azusawab,

Tokuko Toyotaa, Tadahiro Hondaa, Mahito Nakanishie, Koichi Ohshimaf, Ayako Masudag, Emiko Yoshidag, Mari Kitadeg,

Matthew Porteusc, Yasuhisa Teraog, Hiromitsu Nakauchid, and Miki Andoa

Title of original paper


iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer



Cell Reports Medicine







aDepartment of Hematology, Juntendo University School of Medicine

bDivision of Cell Therapy & Blood Transfusion Medicine, Juntendo University School of Medicine

cDepartment of Pediatrics, School of Medicine, Stanford University

dInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine

eTOKIWA-Bio, Inc., Tsukuba Center Inc. (TCI)

fDepartment of Pathology, School of Medicine, Kurume University

gDepartment of Obstetrics and Gynecology, Juntendo University School of Medicine


About Professor Miki Ando from Juntendo University

Dr. Miki Ando is a certified hematologist with over twenty years of experience in research and patient care. She obtained her Ph.D. in 2005 from Juntendo University, where she currently serves as Chairperson of the Department of Hematology. Her most recent work focuses on stem cell regulation, iPSCs, and their potential for cancer therapy. She has published over 60 papers on these topics and has been cited numerous times.


[Attachments] See images for this press release:
Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer 2


Humans have driven the Earth’s freshwater cycle out of its stable state

A new analysis of freshwater resources across the globe shows that human activity has pushed variation in the planet’s freshwater cycle well outside of its pre-industrial range. The study shows that the updated planetary boundary for freshwater change was surpassed by the mid-twentieth century. In other words, for the past century, humans have been pushing the Earth’s freshwater system far beyond the stable conditions that prevailed before industrialization. This is the first time that global water cycle change has been assessed over such a long timescale with an appropriate reference baseline. The findings, published in Nature Water, show that human ...

Exposure to different kinds of music influences how the brain interprets rhythm

CAMBRIDGE, MA -- When listening to music, the human brain appears to be biased toward hearing and producing rhythms composed of simple integer ratios — for example, a series of four beats separated by equal time intervals (forming a 1:1:1 ratio). However, the favored ratios can vary greatly between different societies, according to a large-scale study led by researchers at MIT and the Max Planck Institute for Empirical Aesthetics and carried out in 15 countries. The study included 39 groups of participants, many of whom came from societies ...

Study shows differences in how patients with impulse control disorder process consequences

Study shows differences in how patients with impulse control disorder process consequences
WINSTON-SALEM, N.C. – March 4, 2024 – Parkinson’s disease is a neurological disorder that affects movement and muscle control. One characteristic of the disease is the deficiency of dopamine, a neurotransmitter or brain chemical that plays a role in movement and can impact how people think and feel. Dopaminergic medicines can help alleviate the symptoms of Parkinson’s disease. However, in some patients, the medications can cause impulse control disorder (ICD), characterized by risky behavior such as excessive gambling, shopping, ...

Improving access to early-stage lung cancer care in Europe

There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times and indications between the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Researchers from Amsterdam UMC Cancer Center Amsterdam analysed the landscape, and their results are published today in The Lancet Regional Health Europe as part of a series on the latest developments in the treatment of this lung cancer.   "Tackling inequalities in access to care must be a common European priority," ...

Low iron levels resulting from infection could be key trigger of long COVID

Problems with iron levels in the blood and the body’s ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID, new research has discovered. The discovery not only points to possible ways to prevent or treat the condition, but could help explain why symptoms similar to those of long COVID are also commonly seen in a number of post-viral conditions and chronic inflammation. Although estimates are highly variable, as many as three in 10 people infected with SARS-CoV-2 could go on to develop long COVID, with symptoms including fatigue, ...

Swapping meat for Quorn lowers bad cholesterol by 10-percent

Regularly substituting meat for mycoprotein such as Quorn could help to lower bad cholesterol by 10-percent, which is comparable to switching to a Mediterranean or vegan diet. New research by the University of Exeter, published in Clinical Nutrition, also found substituting meat for Quorn reduces blood glucose and c-peptide concentrations associated with diabetes, cardiovascular disease and all-cause mortality. With one in six UK adults suffering from raised cholesterol, the findings indicate that mycoprotein - the high protein, high-fibre food source that’s the main ingredient in Quorn - could play a key role in ...

We must stop technology-driven AI and focus on human impact first, global experts warn

We need to stop designing new AI technology just because we can, causing people to adapt practices, habits and laws to fit the new technology; instead we need to design AI that fits exactly with what we need, according to human-centred AI advocates. Fifty experts from around the world have contributed research papers to a new book on how to make AI more ‘human-centred,’ exploring the risks — and missed opportunities — of not using this approach and practical ways to implement it. The experts come from over 12 countries, including Canada, France, Italy, Japan, New Zealand and the UK, and more ...

NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment

NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment
An important discovery from the NCI-MATCH precision medicine initiative is being published today in Clinical Cancer Research, a journal of the American Association for Cancer Research. Trastuzumab-pertuzumab, a drug combination approved by the US Food and Drug Administration (FDA) to treat patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, shrunk tumors in patients with several other types of cancer with high levels of the HER2 gene. NCI-MATCH (Molecular Analysis for Therapy Choice) is one of the first ...

Obesity a risk factor for stillbirth, especially at term

Obesity is a risk factor for stillbirth, and the risk increases as pregnancy advances to term, according to a large study published in CMAJ (Canadian Medical Association Journal) The overall risk of stillbirth in pregnancy is approximately 0.4% in Canada. "Our findings suggest that an earlier delivery date may help reduce the risk of stillbirth for pregnant people with obesity," says lead author Dr. Naila Ramji, a high-risk pregnancy specialist in Fredericton, New Brunswick, and ...

Pioneering research reveals empathetic communication can help overcome vaccine hesitancy

An international study has shown for the first time how empathetic correction of misinformation among vaccine-hesitant patients can significantly improve attitudes towards vaccination – and potentially boost vaccine uptake. The research, led by the University of Bristol, also found this new style of communication could help build and maintain a positive relationship with health professionals, increasing trust and public confidence. With the UK currently facing a growing measles outbreak, fuelled by declining rates of the Measles, ...


UK/Portuguese study strongly suggests antibiotic-resistant “superbugs” are being passed from cats and dogs to their owners

Researchers study effects of solvation and ion valency on metallopolymers

Physicists solve puzzle about ancient galaxy found by Webb telescope

Clear guidelines needed for synthetic data to ensure transparency, accountability and fairness study says

Report finds significant gender and racial inequities in the educational measurement profession

University of Houston and Scotland’s Heriot-Watt University forge strategic energy alliance

Rice team demonstrates miniature brain stimulator in humans

Jennifer Stinson receives prestigious Barer-Flood Prize in health services research

First insights into the genetic bottleneck characterizing early sheep husbandry in the Neolithic period

Theories that explain the crisis in democracy are inadequate for Latin America, experts say

Starving cells hijack protein transport stations

Where have all the right whales gone?

Researchers find no link between COVID-19 virus and development of asthma in children

Cell’s ‘garbage disposal’ may have another role: helping neurons near skin sense the environment

Study reveals potential to reverse lung fibrosis using the body’s own healing technique

International team co-led by a BSC researcher discovers more than 50 new deep-sea species in one of the most unexplored areas of the planet

Cleveland Innovation District partners exceeding many targets set by state and JobsOhio

A third of women experience migraines associated with menstruation, most commonly when premenopausal

MD Anderson Research Highlights for April 12, 2024

Soft Robotics appoints new Deputy Editor-in-Chief, Barbara Mazzolai, PhD

Wiley releases Mass Spectra of Designer Drugs 2024 to accelerate forensics analysis of fentanyls, cannabinoids, and more

Freestanding emergency departments are popular, but do they function as intended?

University of Cincinnati experts present at national neurology conference

Bonobos are more aggressive than previously thought

How seaweed became multicellular

Melanomas resist drugs by ‘breaking’ genes

Africa’s iconic flamingos threatened by rising lake levels, study shows

Vaccination timeliness among US children ages 0-19 months

Changes in permanent contraception procedures among young adults following the Dobbs decision

Semaglutide vs endoscopic sleeve gastroplasty for weight loss

[] Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer
Researchers from Japan demonstrate that gene editing can enhances the effectiveness of rejuvenated cytotoxic T lymphocytes for targeted immunotherapy